Q2 2025 Phibro Animal Health Corp Earnings Call Transcript
Key Points
- Phibro Animal Health Corp (PAHC) reported a 24% increase in consolidated net sales for Q2 2025, reaching $309.3 million.
- The animal health segment experienced a significant growth of 33%, driven by strong demand and the integration of the Zoetis Medicated Feed Additives (MFA) portfolio.
- Adjusted EBITDA surged by 64%, showcasing improved profitability and operational efficiency.
- The company successfully integrated the Zoetis MFA portfolio, contributing to a 47% increase in MFA and other product sales.
- Phibro's Phibro Forward initiative continues to drive operational excellence and identify growth opportunities, enhancing long-term value creation.
- Total sales declined by 24%, indicating challenges in other segments despite strong performance in animal health.
- Increased SG&A expenses due to higher employee-related costs partially offset the gains in gross profit.
- The integration of the Zoetis MFA portfolio faced transition challenges, including blackout periods and destocking impacts.
- Corporate expenses increased by $3.4 million, driven by higher employee-related costs.
- Potential geopolitical challenges, such as tariffs, could impact cost structures, although mitigation plans are in place.
Hello and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time. I would like to welcome everyone to the Fibro Animal Health Corporation second quarter, 2025 earnings conference call.
(Operator Instructions) I would now like to turn the conference over to Glenn David, Chief Financial Officer. Please go ahead.
Thank you, Regina. Good morning and welcome to the fibro Animal Health Corporation earnings call for our second quarter ended December 31st, 2024. My name is Glenn David, and I'm the Chief Financial Officer of Fibro Animal Health Corporation. I am joined on today's call by Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer and Daniel Bendheim, Director and Executive Vice President of corporate strategy.
Today, we will cover our financial performance for our second quarter and provide updated financial guidance for our fiscal year ending June 30th, 2025.
At the conclusion of our remarks,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
